Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Change in Account Payables of $1.8 million for Q1 2026, up 4319.51% year-over-year from $41000.0 in Q1 2025, and up 1308.0% quarter-over-quarter from -$150000.0 in Q4 2025.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Change in Account Payables for 4 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 4319.51% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.0 million (up 447.42% YoY), while the FY2025 annual figure was -$760000.0, down 246.44% from the prior year.
- Change in Account Payables advanced to $1.8 million in Q1 2026 per ARTV's latest filing, from -$150000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.8 million in Q1 2026 and bottomed at -$1.9 million in Q4 2023.
- Historically, Change in Account Payables has averaged $112272.7 across 4 years, with a median of -$82000.0 in 2024.
- Annual changes were most pronounced in 2025 — Change in Account Payables slumped 162.78% — and 2026, when it soared 4319.51%.
- Artiva Biotherapeutics' Change in Account Payables stood at -$1.9 million in 2023, then surged by 95.73% to -$82000.0 in 2024, then plunged by 82.93% to -$150000.0 in 2025, then surged by 1308.0% to $1.8 million in 2026.
- Business Quant data shows ARTV's Change in Account Payables at $1.8 million in Q1 2026, -$150000.0 in Q4 2025, and -$442000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - | -780,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -780,000.00 |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | -442,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Sep 30, 2024 | 704,000.00 |
| Jun 30, 2024 | -954,000.00 |
| Mar 31, 2024 | 851,000.00 |
| Dec 31, 2023 | -1.92 Mn |
| Sep 30, 2023 | 1.59 Mn |